November 2023 | AIChE

You are here

November 2023

AZ, Eccogene ink deal for cardiometabolic disease drug

AstraZeneca and China's Eccogene have signed an exclusive license agreement that grants AZ global rights to ECC5004, an inves - More -

Refiners report strong 3rd-quarter performance

US refiners posted strong third-quarter revenues and higher refining margins amid rising demand and commodity prices. - More -

Pages